• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Thromb Res . Haemostatic changes following ECMO circuit replacement in adult patients with COVID-19: An exploratory retrospective study

tetano

Editor, Senior Moderator
Thromb Res


. 2025 Nov 17:257:109542.
doi: 10.1016/j.thromres.2025.109542. Online ahead of print. Haemostatic changes following ECMO circuit replacement in adult patients with COVID-19: An exploratory retrospective study

Bernhard Nagler[SUP] 1 [/SUP], Sabrina Thurner[SUP] 1 [/SUP], Peter Schellongowski[SUP] 1 [/SUP], Oliver Robak[SUP] 1 [/SUP], Alexander Hermann[SUP] 1 [/SUP], Thomas Staudinger[SUP] 2 [/SUP], Nina Buchtele[SUP] 1 [/SUP]



Affiliations
Free article Abstract

Background: Extracorporeal membrane oxygenation (ECMO) is an important intervention for severe respiratory failure, yet coagulation abnormalities and circuit thrombosis remain significant challenges. Circuit exchanges are frequently performed to restore oxygenator function and mitigate ECMO-related coagulopathies, but optimal criteria for their indication remain unclear.
Methods: This retrospective analysis included adult patients with coronavirus disease 2019 associated acute respiratory distress syndrome (ARDS) receiving venovenous (VV) ECMO at a tertiary hospital between January 2020 and April 2023. The primary endpoint was the change in d-dimer level on the third day after a circuit exchange compared to the last value before the circuit exchange. Secondary analyses included parameters such as fibrinogen, platelet count, LDH, post‑oxygenator pO[SUB]2[/SUB] and transmembrane pressure. Statistical comparisons were made using Wilcoxon-signed-rank tests and linear mixed models.
Results: Among 48 patients, 37 (77.1 %) underwent at least one coagulation-related circuit exchange, totalling 96 exchanges. D-dimer levels significantly decreased from 19 μg/ml (IQR 11-25) before exchange to 4 μg/ml (IQR 2-7) after exchange (p < 0.001). Platelet counts increased significantly (p = 0.024), while LDH levels decreased (p = 0.001). No significant changes were observed in fibrinogen levels. A sharp increase in d-dimer prior to exchange correlated with subsequent decreases post-exchange (R = -0.66, p < 0.001).
Conclusions: ECMO circuit exchanges are associated with significant improvements in coagulation parameters, particularly d-dimer reduction, suggesting that d-dimer trends may serve as a key indicator for elective circuit replacement. Future prospective studies should refine exchange criteria to optimize patient outcomes while minimizing unnecessary interventions.

Keywords: Coagulation; D-dimer; ECMO; Fibrinolysis; Haemostasis; Platelets; Thrombosis.

 
Back
Top